A collaborative research team from Mansoura University and Charles Drew University of Medicine and Science has published a groundbreaking study on BioBran, titled “Nanoparticle-Enhanced Protective Effects of MGN-3/BioBran Against Ehrlich Ascites Carcinoma-Induced Toxicity in the Liver, Kidneys, and Spleen of Mice.”

The research demonstrated that BioBran-loaded nanoparticles significantly reduced tumor weight while protecting the liver, kidneys, and spleen from cancer-induced damage in a mouse model. The nanoparticle formulation proved substantially more effective than standard BioBran, demonstrating improved therapeutic efficacy and enhanced bioavailability.
These findings strongly support the potential of nanoparticle-enhanced BioBran as a promising natural adjuvant therapy in cancer treatment.

Journal: Mansoura Journal of Biology 2025, 72(2), 28-40
Authors: Zeinab A. Mostafa, Mai Alaa El-Dein, Mamdooh Ghoneum, and Nariman K. Badr El-Din